medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Protocol for an observational study evaluating new approaches to modelling diagnostic
information from large administrative hospital datasets

Thomas E Cowling1,3

Assistant Professor in Clinical Epidemiology

David A Cromwell1,3

Professor of Health Services Research

Linda D Sharples2

Professor of Medical Statistics

Jan van der Meulen1,3

Professor of Clinical Epidemiology

London School of Hygiene and Tropical Medicine, Keppel St, London, UK
1Department

of Health Services Research and Policy

2Department

of Medical Statistics

Royal College of Surgeons of England, Lincoln‚Äôs Inn Fields, London, UK
3Clinical

Effectiveness Unit

Correspondence to: thomas.cowling@lshtm.ac.uk

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Abstract

Introduction: The Charlson and Elixhauser indices define sets of conditions used to adjust for
patients‚Äô comorbidities in administrative hospital data. A strength of these indices is the parsimony
that results from including only 19 and 30 conditions respectively, but the conditions included may
not be the ones most relevant to a specific outcome and population. Our objectives are to: (1) test
an approach to developing parsimonious indices for the specific outcome and populations being
studied, while comparing performance to the Charlson and Elixhauser indices; and (2) evaluate
several approaches that involve models with more diagnosis-related terms and aim to improve
prediction performance by capturing more of the information in large datasets.
Methods and analysis: This is a modelling study using a linked national dataset of administrative
hospital records and death records. The study populations are patients admitted to hospital for
acute myocardial infarction, hip fracture, or major surgery for colorectal cancer in England between
1 January 2015 and 31 December 2017. The outcome is death within 365 days of the date of
admission (acute myocardial infarction and hip fracture) or procedure (colorectal surgery). In the
‚ÄòFirst analysis‚Äô, prognostic indices will be developed based on the presence/absence of individual
ICD-10 codes in patients‚Äô medical histories. Logistic regression will be used to estimate
associations with a full set of sociodemographic and diagnostic predictors from which reduced
models (with fewer diagnostic predictors) will be produced using a step-down approach. In the
‚ÄòSecond analysis‚Äô, models will also account for the timing that each ICD-10 code was last recorded
and allow for non-linear relationships and interactions between conditions and the timings of
records. Validation will include an overall measure of performance (scaled Brier score) and
measures of discrimination (c-statistic) and calibration (such as the Integrated Calibration Index)
in bootstrap or cross-validation samples. Sensitivity analyses will include varying the length of
medical history analysed, using a comparator that combines the Charlson and Elixhauser sets of
conditions, and aggregating ICD-10 codes into clinical groups.

2

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Introduction

In 1987, Charlson et al.1 proposed a set of comorbidities that could be used to predict patient
mortality in longitudinal studies. The corresponding article is now the 3rd most cited article of all
time in the ‚ÄòMedicine, General and Internal‚Äô category of the Web of Science2 with almost 30,000
citations (Google Scholar). The wider set of comorbidities proposed in 1998 by Elixhauser et al.3,
for use with large administrative hospital datasets, has almost 6,000 citations. These two indices
are a cornerstone of modern clinical research and healthcare evaluation: they are often used to
assess and reduce confounding of outcomes between trial arms,4-6 observed treatment groups,7-9
and healthcare providers.10-12 They are also often included in prediction models.13-15
These indices are likely to be popular partly because they are highly transparent, reproducible,
and parsimonious. The Charlson1 and Elixhauser3 indices include 19 and 30 conditions,
respectively, which have well-established International Classification of Diseases (ICD) coding
methods.16 The weighted number of conditions is often used as a summary measure.1,17
However, the relatively small number of conditions included in each index may not account for the
ones most relevant to a specific outcome and population,18 thus limiting the degree to which
confounding is reduced. Several authors have therefore suggested approaches that include more
conditions.19-22 For example, in 2005, Holman et al.23 used the 100 commonest ICD codes in the
population to define candidate predictor variables. While this approach performed better than the
Charlson index in its development study,23 it has not been widely used (with less than 100 citations
on Google Scholar). This may be partly because the large number of variables is likely to increase
the risk that models fitted in smaller datasets do not generalise well to other datasets. It is also
more time-consuming to apply and present a larger model in different studies.
This highlights the need for a new approach to developing prognostic indices that considers a large
number of candidate conditions but produces a final model with a relatively small number of
conditions that account for most of the explainable variation in the outcome. This model is adapted
to the specific outcome and population being studied and should share the strengths of the
Charlson and Elixhauser indices given above, especially their parsimony.
Several studies focusing on risk prediction in large datasets, rather than a comorbidity index in
itself, have developed particularly large models with many more diagnosis-related predictors.
These models have accounted for the timing of diagnosis records24-26 and were estimated using
machine learning methods that do not assume a simple functional form for associations between
outcomes and predictors.24-28 This could help these approaches to better predict outcomes than
more conventional methods, but this has not been tested or quantified empirically in the existing
literature. Moreover, more complex models may be less interpretable and reproducible than
simpler ones, which may negate any benefits in terms of prediction performance.
In this study, we will: (1) test an approach to developing parsimonious prognostic indices, based
on ICD-10 codes, for the specific outcome and populations being studied, while comparing
performance to the Charlson and Elixhauser indices; and (2) evaluate several approaches that

3

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

involve models with more diagnosis-related terms and aim to improve prediction performance by
capturing more of the information in large datasets.
The study outcome and populations will be 1-year mortality of acute myocardial infarction, hip
fracture, and major colorectal cancer surgery patients in England. We have chosen to analyse
specific groups rather than all inpatients as most studies using comorbidity methods focus on
clinical populations defined by disease, events, or interventions, so comparisons of methods are
most informative (and most common18) when done within clinical groups.23
We chose these three groups to illustrate the general applicability of the approaches. The groups
correspond to a large number of admissions per year but vary in terms of the clinical areas affected,
the conditions that coexist, and mortality rates. Most deaths amongst patients admitted for hip
fracture are due to other conditions, both in the short and longer terms,29,30 with a 1-year mortality
rate of approximately 30%.31 In contrast, acute myocardial infarction presents a greater risk of
death in itself; most deaths within 30 days of admission for this condition are due to the primary
event.32 Unlike these two conditions, most major surgery for colorectal cancer is planned and the
1-year mortality rate is less than 10%.36 The approaches will therefore be tested in a
heterogeneous group of conditions where performance is more likely to vary.

4

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Methods

Study populations
We will conduct a modelling study using a large national dataset of administrative hospital records.
The Hospital Episode Statistics Admitted Patient Care dataset includes all inpatient hospital care
funded by the National Health Service (NHS) in England.37
The three study populations are patients admitted to hospital for acute myocardial infarction (ICD10: I21-2238,39), hip fracture (S72.0-S72.240,41), or major surgery for colorectal cancer (C18-20;
OPCS-4: H04-11, H29, H33, X1442-45). Acute myocardial infarction and hip fracture patients will be
identified from the ICD-10 code recorded as the primary diagnosis for the first episode in each
admission. Colorectal surgery patients will be identified from the primary diagnosis of any episode
with a relevant OPCS-4 code recorded for the main procedure of that same episode.
We will analyse patients aged 18 years or older in the acute myocardial infarction and major
colorectal surgery populations and aged 60 years or older41 in the hip fracture population. We will
include those with a relevant admission from 1 January 2015 to 31 December 2017.
Each record in Hospital Episode Statistics corresponds to an ‚Äòepisode‚Äô, defined as a continuous
period of hospital care under the same consultant doctor. Each episode has 20 diagnosis fields
which contain ICD-10 codes corresponding to diagnoses recorded for that specific episode. The
first field contains the primary diagnosis‚Äîthe main condition treated or investigated during that
episode. The other 19 fields contain secondary diagnoses. Three-character categories of ICD-10
codes define single conditions or groups of diseases with a common characteristic; fourth
characters are used variably to define sites, subtypes, and causes.46
Outcome
The outcome variable is death within 365 days of the date of admission (acute myocardial infarction
and hip fracture) or procedure (major colorectal surgery). Death in hospital or within 30 days and
365 days of admission are the commonest outcome variables in studies comparing comorbidity
methods18,47; we will focus on the 365 days period (as in Charlson et al.1) as in-hospital and 30day mortality may be much more strongly affected by the primary event than other conditions. In
addition, 30-day mortality after colorectal excision is less than 3%.36 If a patient has more than one
index admission of the same type (such as two admissions for hip fracture), the earliest date of
these admissions from 2015 to 2017 will be taken as the index date.
We will identify dates of death from Civil Registrations Data.48 We have these records up to 31
December 2018, providing complete follow-up for the outcome. Death records were linked to
Hospital Episode Statistics using deterministic linkage on each patient‚Äôs unique NHS number, date
of birth, sex, and postcode.

5

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

First analysis ‚Äì Parsimonious models
Definition of predictors
We will analyse diagnosis codes from episodes that started within 365 days before the index date
of each patient. We will use the three-character categories of ICD-10 codes only (excluding fourth
characters) to increase the frequencies of predictors so that model predictions are more reliable.
In each population, we will exclude code categories recorded for less than 0.5% of patients as
these codes are so rare that they are unlikely to explain much variation in outcomes.25,49
We will define a binary predictor variable for each code that denotes whether that code was
recorded or not within 365 days before a patient‚Äôs index date. We chose this 1-year ‚Äòlook-back
period‚Äô rather than only using information from the index admission as the former approach can
also be applied in non-inpatient populations and some studies suggest that it improves model
performance.18
Patient age (coded as a continuous variable) at the index date, sex, and socioeconomic status will
be predictors in all models, as is common when comparing comorbidity indices.18,47 Socioeconomic
status will be measured by the national rank of the Index of Multiple Deprivation score for the lower
super output area in which a patient lived; these areas are ranked from 1 (most deprived) to 32,482
(least deprived) and have population sizes between 1,000 and 3,000.50
Model estimation
We will first estimate associations between the outcome and the full set of predictors as the
maximum likelihood estimates from logistic regression. Interaction terms will not be considered.
We will then develop a reduced model that approximates this full model using the backwards stepdown approach proposed by Harrell.51,52
First in this approach, the predicted log-odds of the outcome for each patient is calculated from the
coefficients of the full model. Second, an ordinary least squares regression model is fitted between
these values and the full set of predictors (with an R2 value of 1 by definition). Third, R2 is calculated
for a series of models in which each successive model has an additional predictor removed, in a
backwards step-down process based on likelihood ratio estimates.51,53 This process will stop when
all predictors have been removed. Fourth, the model with the fewest predictors and an R2 value
equal to or greater than 0.95 will be selected as the final reduced model. This model will explain at
least 95% of the variation in the outcome explained by the full set of predictors.
Comparators
We will compare this resulting prediction approach to the Charlson1 and Elixhauser3 methods, as
systematic reviews found them to be the most commonly used comorbidity indices by far.18,47
An established list of ICD-10 codes16 will be used to identify whether each condition included in
these indices was recorded or not within 365 days before the index date. This list categorises the
Charlson1 and Elixhauser3 conditions into 17 and 31 groups, respectively; 14 of the 17 Charlson
groups are also included in the Elixhauser groups.54 We will estimate associations between the
outcome and each condition using multivariable logistic regression, separately for the two sets of

6

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

conditions. We will model a binary predictor variable for each condition rather than an overall
weighted summary measure, as optimal weights differ across datasets, populations, outcomes,
and time.3,33 Systematic reviews of comorbidity indices suggest that modelling conditions using
this approach generally improves prediction performance.18,47
Second analysis ‚Äì Larger models
Use of diagnosis timings as predictors
The analysis described above will model the presence or absence of each ICD-10 code within a
year before the index dates. In the second analysis, we will use a longer look-back period of five
years and define an additional predictor for each ICD-10 code that records the number of days
before the index date that the code was last recorded (from 0 to 1825 days). Logistic regression
will be used to estimate the coefficients of the following model:
log (

ùúãùëñ
) = ùõº + ùõΩ1 ùë•1ùëñ + ùõæ1 ùë•1ùëñ ùë°1ùëñ + ‚ãØ + ùõΩùëù ùë•ùëùùëñ + ùõæùëù ùë•ùëùùëñ ùë°ùëùùëñ
1 ‚àí ùúãùëñ

where ùúãùëñ is the predicted probability of death for individual ùëñ, each of the variables ùë•ùëòùëñ represents
a binary indicator denoting the presence (1) or absence (0) of the ùëòth ICD-10 code (in the lookback period) for individual ùëñ and ùë°ùëòùëñ is a continuous variable denoting the corresponding number of
days between the last record of that code and the date of the index admission/procedure. The
model parameters are interpreted as follows:
ÔÇ∑
ÔÇ∑
ÔÇ∑

ùõº represents the log-odds of death within 365 days for a person without any ICD-10 codes
recorded
ùõΩùëò , ùëò = 1, ‚Ä¶ , ùëù is the change in log-odds of death for the ùëòth ICD-10 code on the day of the
index admission/procedure
ùõæùëò , ùëò = 1, ‚Ä¶ , ùëù is the change in log-odds of death per day for the interval between the last
record of a given ICD-10 code and the index admission/procedure

Patient age, sex, and socioeconomic status will also be included as predictors (as before) and are
omitted from the equation above only for clarity.
This equation assumes linear relationships between the timings that ICD-10 codes were last
recorded and the log-odds of death. To relax this assumption, we will also fit generalised additive
models that include non-linear associations for the predictors using smoothing splines.55,56
Use of boosted trees to account for interactions
A potential limitation of the approaches described above for the first and second analyses is that
they do not model interactions between conditions. As conditions could modify each other‚Äôs effects
on prognosis, we will also test the performance of boosted tree models. These models have the
potential benefit of modelling interactions between conditions without these interactions having to
be pre-specified, unlike when using conventional logistic regression for example. The approach
involves fitting a series of decision trees to the data sequentially with each tree attempting to
improve on the predictions of the previous tree (termed ‚Äòboosting‚Äô).

7

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

We will use the gradient boosted tree approach of Friedman et al.57-59 as implemented in the
XGBoost60 R package (explained accessibly elsewhere61-63). This is a popular statistical learning
algorithm that has outperformed other methods in large routine healthcare datasets with many
predictors.24,26,28 The tuning parameters of the algorithm are given in Appendix 1.
Validation methods
For all analyses, Brier scores will be calculated to assess the overall predictive performance of the
approaches.64 These scores equal the mean of squared differences between the predicted
probability of death and the observed death outcome. Since Brier scores are affected by the overall
risk of the outcome, we will scale these scores (Brierscaled) to account for the maximum possible
value (Briermax) given the overall risk of death: Brierscaled = 1 ‚Äì Brier/Briermax.65 Larger values of
Brierscaled are better: this measure equals 100% when predictions are perfect and 0% when the
predicted probability of death for each patient equals the overall risk of death in the population.
To assess discrimination, we will calculate the c-statistic.66 This measure equals the probability
that a randomly chosen patient who died had a greater predicted probability of death than a
randomly chosen patient who did not die; it assesses the rank order of predictions. A perfect model
would have a value of 1 and a set of random predictions would have a value of 0.5.
To assess model calibration, we will calculate calibration-in-the-large, calibration slopes,67 and the
Integrated Calibration Index (ICI).68 Calibration-in-the-large is the difference in means between
predicted probabilities and observed death outcomes, such that perfect models have values of
zero. Calibration slopes equal the coefficient of the predicted log-odds of death in a logistic
regression model with the log-odds of death as the outcome variable and no other predictors;
perfect models have slopes equal to one. The ICI is a weighted average of absolute differences
between a calibration curve and the diagonal line of perfect calibration68; the perfect ICI is zero.
In the ‚ÄòFirst analysis‚Äô, we will calculate the above measures in the entire dataset used to fit the
regression models (‚Äòapparent performance‚Äô) and also optimism-corrected estimates of these
measures using the bootstrapping procedure given in the TRIPOD guidelines69-71; 500 bootstrap
samples will be used with all modelling steps repeated in each sample.
In the ‚ÄòSecond analysis‚Äô, the models will take longer to estimate due to the larger number of
parameters and bootstrapping will be too time-consuming, so a different validation process will be
used. In each population, we will randomly allocate 75% of patients to a ‚Äòtraining‚Äô dataset and the
other 25% to a ‚Äòtest‚Äô dataset. We will first calculate the above performance measures in the training
set using five repeats of 10-fold cross-validation. The results will be used to select the tuning
parameters of the boosted trees that minimise the negative log-likelihood. We will then fit the final
models on the whole training dataset and evaluate their prediction performance in the test dataset.
Sensitivity analyses
Five analyses will test the sensitivity of results to changes in the methods described above for the
‚ÄòFirst analysis‚Äô. First, ICD-10 code categories recorded for less than 1% of patients (rather than
0.5%) will be excluded. Second, we will examine the performance of the full models with diagnostic

8

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

predictors based on the index episode only or a 3-year look-back period (instead of a 1-year
period). Third, we will fit a model using the conditions included in either of the Charlson and
Elixhauser indices,19,22 using the most inclusive ICD-10 code definition of conditions in both
indices.54 Fourth, we will aggregate ICD-10 codes into the groups of the Clinical Classification
Software (CCS) scheme,72,73 excluding groups recorded for less than 0.5% of patients, and reestimating the full models. Fifth, we will assess changes in coefficients of the full models when
penalised maximum likelihood estimation51,74 is used; the penalty factor will be chosen to maximise
a modified Akaike‚Äôs Information Criterion (AIC).51,71,74
The results of these analyses will inform which sensitivity analyses, if any, to also conduct for the
approaches given under ‚ÄòSecond analysis‚Äô above.
We will follow the ‚ÄòTransparent Reporting of a multivariable prediction model for Individual
Prognosis or Diagnosis‚Äô (TRIPOD) guidelines for reporting the study.70 The corresponding articles
will provide code for estimating the different models in R. Data management and preparation will
be done using Stata (v15)75 and R (v3.5)76 will be used for all statistical analysis.

9

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Implications for research

This study will evaluate new approaches to modelling diagnostic information from large
administrative hospital datasets, using mortality as the outcome. These approaches could be
particularly useful for risk adjustment when comparing patient outcomes between treatment groups
or healthcare providers, in addition to being useful for risk prediction models. Based on the study‚Äôs
results, we will suggest which approaches should be considered by other researchers with similar
large datasets depending on the intended purpose of the model developed.
We expect that researchers who aim to develop a parsimonious prognostic index specifically for
the outcome and population being studied could use the approach proposed under ‚ÄòFirst analysis‚Äô
above. This index‚Äîa single measure defined by a weighted number of conditions‚Äîcould then be
incorporated into future models to help reduce confounding or improve the performance of
prediction models. Alternatively, the list of conditions that define the final index (without the
weights) could be used as separate predictor variables in subsequent models. The index could
therefore be used as the Charlson and Elixhauser indices have been; the difference is that the new
approach produces an index that is optimal for a specific outcome and population.
Researchers who do not intend to develop a parsimonious index may prefer one of the approaches
given under ‚ÄòSecond analysis‚Äô. These approaches produce models that have a large number of
diagnostic parameters and are more difficult to interpret but may predict outcomes better. A single
measure can be produced as the predicted log-odds of death based on the diagnostic predictors
in the model. This measure could then be included in future models as before. Alternatively, it may
be preferable to estimate a model with diagnostic information and all other predictors
simultaneously (using the same approaches), such as when it is acceptable for the final model to
represent the conditions as a large number of separate terms.
Each of the approaches involves a large number of predictors such that large sample sizes are
needed to develop the models. The adequate sample size depends on several factors including
the frequencies of the outcome and co-existing conditions in the population. Guidance for
determining adequate sample sizes is available elsewhere.77 Researchers with smaller datasets
can still apply the models developed in larger studies to their own data, including those developed
for acute myocardial infarction, hip fracture, and major colorectal cancer surgery in this study.

10

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

References

1.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic
comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-83.
2.

Web of Science. Available from: www.webofknowledge.com.

3.
Elixhauser A, Steiner C, Harris DR, Coffey RN. Comorbidity measures for use with
administrative data. Medical Care 1998;36(1):8-27.
4.
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative
care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet
2014;383(9930):1721-30.
5.
Pro CI, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial
of protocol-based care for early septic shock. N Engl J Med 2014;370(18):1683-93.
6.
Cohen HJ, Feussner JR, Weinberger M, Carnes M, Hamdy RC, Hsieh F, et al. A controlled trial
of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002;346(12):905-12.
7.
Schermerhorn ML, O'Malley AJ, Jhaveri A, Cotterill P, Pomposelli F, Landon BE. Endovascular
vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med
2008;358(5):464-74.
8.
Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of
colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150(1):1-8.
9.
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation
for prostate cancer. N Engl J Med 2005;352(2):154-64.
10.
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume
and surgical mortality in the United States. N Engl J Med 2002;346(15):1128-37.
11.
Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance
measures and mortality rates. JAMA 2006;296(22):2694-702.
12.
Jha AK, Orav EJ, Li Z, Epstein AM. The inverse relationship between mortality rates and
performance in the Hospital Quality Alliance measures. Health Aff (Millwood) 2007;26(4):1104-10.
13.
Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL, Jr. Prognostic importance of
comorbidity in a hospital-based cancer registry. JAMA 2004;291(20):2441-7.
14.
Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older
adults: a systematic review. JAMA 2012;307(2):182-92.
15.
Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients
hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290(19):2581-7.
16.
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for
defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43(11):1130-9.
17.
van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A Modification of the Elixhauser
Comorbidity Measures into a Point System for Hospital Death Using Administrative Data. Medical Care
2009;47(6):626-33.
18.
Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative
data. Med Care 2012;50(12):1109-18.

11

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

19.
Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score
predicted mortality in elderly patients better than existing scores. J Clin Epidemiol 2011;64(7):749-59.
20.
Stanley J, Sarfati D. The new measuring multimorbidity index predicted mortality better than
Charlson and Elixhauser indices among the general population. J Clin Epidemiol 2017;92:99-110.
21.
Sarfati D, Gurney J, Stanley J, Salmond C, Crampton P, Dennett E, et al. Cancer-specific
administrative data‚Äìbased comorbidity indices provided valid alternative to Charlson and National
Cancer Institute Indices. Journal of Clinical Epidemiology 2014;67(5):586-95.
22.
Thombs BD, Singh VA, Halonen J, Diallo A, Milner SM. The effects of preexisting medical
comorbidities on mortality and length of hospital stay in acute burn injury: evidence from a national
sample of 31,338 adult patients. Ann Surg 2007;245(4):629-34.
23.
Holman CD, Preen DB, Baynham NJ, Finn JC, Semmens JB. A multipurpose comorbidity
scoring system performed better than the Charlson index. J Clin Epidemiol 2005;58(10):1006-14.
24.
Einav L, Finkelstein A, Mullainathan S, Obermeyer Z. Predictive modeling of U.S. health care
spending in late life. Science 2018;360(6396):1462-5.
25.
Elfiky AA, Pany MJ, Parikh RB, Obermeyer Z. Development and Application of a Machine
Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting
Chemotherapy. JAMA Netw Open 2018;1(3):e180926. doi: 10.1001/jamanetworkopen.2018.0926.
26.
Rahimian F, Salimi-Khorshidi G, Payberah AH, Tran J, Ayala Solares R, Raimondi F, et al.
Predicting the risk of emergency admission with machine learning: Development and validation using
linked
electronic
health
records.
PLOS
Medicine
2018;15(11):e1002695.
doi:
10.1371/journal.pmed.1002695.
27.
Avati A, Jung K, Harman S, Downing L, Ng A, Shah NH. Improving palliative care with deep
learning. BMC Med Inform Decis Mak 2018;18(Suppl 4):122. doi: 10.1186/s12911-018-0677-8.
28.
Jung K, Sudat SEK, Kwon N, Stewart WF, Shah NH. Predicting Need for Advanced Illness or
Palliative Care In A Primary Care Population Using Electronic Health Record Data. J Biomed Inform
2019:103115. doi: 10.1016/j.jbi.2019.103115.
29.
National Clinical Guideline Centre. The Management of Hip Fracture in Adults. 2011. Available
from: https://www.nice.org.uk/guidance/cg124/evidence/full-guideline-pdf-183081997.
30.
Chatterton BD, Moores TS, Ahmad S, Cattell A, Roberts PJ. Cause of death and factors
associated with early in-hospital mortality after hip fracture. Bone Joint J 2015;97-B(2):246-51.
31.
Metcalfe D, Zogg CK, Judge A, Perry DC, Gabbe B, Willett K, et al. Pay for performance and
hip fracture outcomes: an interrupted time series and difference-in-differences analysis in England and
Scotland. Bone Joint J 2019;101-B(8):1015-23.
32.
Asaria P, Elliott P, Douglass M, Obermeyer Z, Soljak M, Majeed A, et al. Acute myocardial
infarction hospital admissions and deaths in England: a national follow-back and follow-forward recordlinkage study. The Lancet Public Health 2017;2(4):e191-e201. doi: 10.1016/s2468-2667(17)30032-4.
33.
Bottle A, Aylin P. Comorbidity scores for administrative data benefited from adaptation to local
coding and diagnostic practices. J Clin Epidemiol 2011;64(12):1426-33.
34.
Nuffield
Trust.
Stroke
and
heart
attack
mortality.
https://www.nuffieldtrust.org.uk/resource/stroke-and-heart-attack-mortality.

Available

from:

35.
Dobbins TA, Creighton N, Currow DC, Young JM. Look back for the Charlson Index did not
improve risk adjustment of cancer surgical outcomes. J Clin Epidemiol 2015;68(4):379-86.

12

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

36.
Boyle J, Braun M, Hill J, Kuryba A, van der Meulen J, Walker K, et al. National Bowel Cancer
Audit Annual Report 2018. Available from: https://www.nboca.org.uk/content/uploads/2018/12/NBOCAannual-report2018.pdf.
37.
Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P. Data Resource Profile: Hospital
Episode Statistics Admitted Patient Care (HES APC). Int J Epidemiol 2017;46(4):1093-i. doi:
10.1093/ije/dyx015.
38.
Metcalfe A, Neudam A, Forde S, Liu M, Drosler S, Quan H, et al. Case definitions for acute
myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health
Serv Res 2013;48(1):290-318.
39.
McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA. Validity of myocardial infarction diagnoses
in administrative databases: a systematic review. PLoS One 2014;9(3):e92286. doi:
10.1371/journal.pone.0092286.
40.
Toson B, Harvey LA, Close JC. The ICD-10 Charlson Comorbidity Index predicted mortality but
not resource utilization following hip fracture. J Clin Epidemiol 2015;68(1):44-51.
41.
Royal College of Physicians. National Hip Fracture Database (NHFD) annual report 2016.
2016. Available from: https://www.nhfd.co.uk/report2016.
42.
Burns EM, Bottle A, Aylin P, Darzi A, Nicholls RJ, Faiz O. Variation in reoperation after
colorectal surgery in England as an indicator of surgical performance: retrospective analysis of Hospital
Episode Statistics. BMJ 2011;343:d4836. doi: 10.1136/bmj.d4836.
43.
Byrne BE, Mamidanna R, Vincent CA, Faiz O. Population-based cohort study comparing 30and 90-day institutional mortality rates after colorectal surgery. Br J Surg 2013;100(13):1810-7.
44.
Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, et al. Thirty-day
postoperative mortality after colorectal cancer surgery in England. Gut 2011;60(6):806-13.
45.
Redaniel MT, Martin RM, Blazeby JM, Wade J, Jeffreys M. The association of time between
diagnosis and major resection with poorer colorectal cancer survival: a retrospective cohort study. BMC
Cancer 2014;14(1):642.
46.
World Health Organization. International Statistical Classification of Diseases and Related
Health
Problems
10th
revision
(5th
edition).
2016.
Available
from:
https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2016.pdf.
47.
Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D. A systematic review
identifies valid comorbidity indices derived from administrative health data. J Clin Epidemiol
2015;68(1):3-14.
48.
Office
for
National
Statistics.
Deaths.
Available
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.

from:

49.
Krumholz HM, Coppi AC, Warner F, Triche EW, Li SX, Mahajan S, et al. Comparative
Effectiveness of New Approaches to Improve Mortality Risk Models From Medicare Claims Data. JAMA
Netw Open 2019;2(7):e197314. doi: 10.1001/jamanetworkopen.2019.7314.
50.
Ministry of Housing, Communities & Local Government,. English indices of deprivation.
Available from: https://www.gov.uk/government/collections/english-indices-of-deprivation.
51.

Harrell FE, Jr. Regression Modeling Strategies. New York: Springer; 2015.

52.
Ambler G, Brady AR, Royston P. Simplifying a prognostic model: a simulation study based on
clinical data. Stat Med 2002;21(24):3803-22.

13

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

53.
Lawless JF, Singhal K. Efficient Screening of Nonnormal Regression-Models. Biometrics
1978;34(2):318-27.
54.
Simard M, Sirois C, Candas B. Validation of the Combined Comorbidity Index of Charlson and
Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10. Med Care 2018;56(5):441-7.
55.

Hastie T, Tibshirani R. Generalized Additive Models. London: Chapman & Hall; 1990.

56.
Hastie TJ. Generalized additive models. In: Chambers JM, Hastie TJ, editors. Statistical Models
in S. London: Chapman & Hall; 1993.
57.
Friedman JH. Greedy function approximation: A gradient boosting machine. Annals of Statistics
2001;29(5):1189-232.
58.
Friedman J, Hastie T, Tibshirani R. Additive logistic regression: a statistical view of boosting
(With discussion and a rejoinder by the authors). The Annals of Statistics 2000;28(2):337-407.
59.
Friedman JH. Stochastic gradient boosting. Computational Statistics & Data Analysis
2002;38(4):367-78.
60.
Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. arXiv 2016. doi:
10.1145/2939672.2939785.
61.

Kuhn M, Johnson K. Applied Predictive Modeling. New York: Springer; 2013.

62.
James G, Witten D, Hastie T, Tibshirani R. An Introduction to Statistical Learning with
Applications in R. New York: Springer; 2013.
63.
Chen T, He T, Benesty M. XGBoost R Tutorial. Available from:
project.org/web/packages/xgboost/vignettes/xgboostPresentation.html.

https://cran.r-

64.
Brier GW. Verification of Forecasts Expressed in Terms of Probability. Monthly Weather Review
1950;78(1):1-3.
65.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the
performance of prediction models: a framework for traditional and novel measures. Epidemiology
2010;21(1):128-38.
66.
Harrell FE, Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests.
JAMA 1982;247(18):2543-6.
67.
Cox DR. Two further applications of a model for binary regression. Biometrika 1958;45(34):562-5.
68.
Austin PC, Steyerberg EW. The Integrated Calibration Index (ICI) and related metrics for
quantifying the calibration of logistic regression models. Stat Med 2019;0(0). doi: 10.1002/sim.8281.
69.
Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models,
evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15(4):36187.
70.
Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al.
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis
(TRIPOD): explanation and elaboration. Ann Intern Med 2015;162(1):W1-73. doi: 10.7326/M14-0698.
71.

Steyerberg EW. Clinical Prediction Models. New York: Springer; 2009.

72.
Healthcare Cost and Utilization Project. Clinical Classifications Software (CCS) for ICD-9-CM.
Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp#download.

14

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

73.
NHS Digital. Summary Hospital-level Mortality Indicator (SHMI): ICD-10 to SHMI diagnosis
group lookup table. Available from: https://digital.nhs.uk/data-and-information/publications/cihub/summary-hospital-level-mortality-indicator-shmi.
74.
Verweij PJ, Van Houwelingen HC. Penalized likelihood in Cox regression. Stat Med
1994;13(23-24):2427-36.
75.

StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC; 2017.

76.
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R
Foundation for Statistical Computing; 2017. Available from: https://www.r-project.org/.
77.
Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE, Jr., Moons KG, et al. Minimum sample size
for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med
2018. doi: 10.1002/sim.7992.
78.
Kuhn M. Building Predictive Models in R Using the caret Package. Journal of Statistical
Software 2008;28(5):1-26.

15

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Contributors TEC conceived the initial idea for the work and designed the study with substantial
contributions from DAC, LDS, and JvdM. TEC will conduct the analysis for this study. TEC drafted
the initial study protocol. All authors commented on draft manuscripts and approved this version
of the protocol.
Funding This work was supported by a Medical Research Council fellowship awarded to TEC
(grant number: MR/S020470/1).
Competing interests None to declare.
Ethical approval Hospital Episode Statistics and Civil Registrations Data were made available by
NHS Digital; approval for the use of the data was obtained from NHS Digital as part of the standard
approval process (digital.nhs.uk).

16

medRxiv preprint doi: https://doi.org/10.1101/19011338; this version posted November 8, 2019. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Appendix 1. Tuning parameters of gradient boosted trees

We will use the caret78 package in R to tune the gradient boosted trees fitted by the XGBoost
package. The final model will use the values of tuning parameters that minimised the negative loglikelihood for binary outcome variables. The parameters and the values tested will be:
Parameter

Description

Values tested

Number of iterations

Maximum number of boosting iterations

1 and 25 to 500
(in steps of 25)

Learning rate

Scales the contribution of each tree‚Äôs predictions by this
value when added to the existing model (shrinkage)

0.05 and 0.1

Maximum tree depth

Highest level of predictor interactions allowed in a tree

3 and 5

Minimum node weight Stops tree splitting if the sum of observation weights in a
node is less than this parameter

100 and 1000

Subsample fraction

0.5 and 1

Fraction of observations in the training dataset randomly
chosen to fit the next tree

The parameter values to test were chosen partly based on the default values of the XGBoost
package as well as the gbm package (which also implements gradient boosted trees). For each
parameter, we will test values that are as or more conservative than the defaults in these packages
to reduce the risk of overfitting. More conservative values correspond to fewer boosting iterations;
lower learning rates, tree depths, and subsampling fractions; and greater minimum node weights.
Overall, 336 unique combinations of the parameter values will be tested.

17

